CASTRATION-SENSITIVE PROSTATE CARCINOMA
Clinical trials for CASTRATION-SENSITIVE PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-SENSITIVE PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for CASTRATION-SENSITIVE PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Prostate cancer patients may get a break from hormone therapy in new trial
Disease control OngoingThis study looks at whether men with metastatic prostate cancer that responds extremely well to hormone therapy can safely take a break from treatment. The goal is to see if their testosterone levels can recover and how long they can stay off therapy without the cancer worsening.…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 08:38 UTC
-
New cocktail aims to knock out metastatic prostate cancer
Disease control OngoingThis study tests a combination of three drugs (apalutamide, abiraterone, and prednisone) given after chemotherapy for men with advanced prostate cancer that has spread and hasn't been treated before. The goal is to see if this approach can lower PSA levels more effectively and al…
Matched conditions: CASTRATION-SENSITIVE PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 22, 2026 13:54 UTC